|
|
||||||||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Wed., Jan. 20, 8:00 PM
|
|||||||||||||||||||||||||||||||||||||||||||||
Secondary Stock Offerings| This Slide: #3 of 25 |
Slide #3. Cryoport, Inc. — Secondary Offering
Company:
Cryoport, Inc. (NASDAQ:CYRX)
Date announced:
1/19/2021
Secondary Offering Details:
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that it intends to offer $200 million of shares of common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Cryoport also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price. All of the shares in the offering are to be sold by Cryoport.
Cryoport is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Co. operates in two reportable segments: Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment provides a platform of temperature-controlled solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and cold chain logistics capability. The Global Bioservices segment provides a temperature-controlled sample management solution to the life science industry, including specimen storage, sample processing, collection, and retrieval.
CYRX SEC Filing Email Alerts Service
Open the CYRX Page at The Online Investor »
|
|||||||||||||||||||||
Open the CYRX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.86 out of 4) 77th percentile
(ranked higher than approx. 77% of all stocks covered)
Analysts' Target Price: CYRX Stock Forecast Based on Zacks ABR data; powered by Xignite |
Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.